Literature DB >> 10772299

Pediatric rhabdomyosarcoma of the head and neck: is there a place for surgical management?

H Daya1, H S Chan, W Sirkin, V Forte.   

Abstract

OBJECTIVE: To review and evaluate the place of surgical treatment in the management of rhabdomyosarcoma of the head and neck in children.
DESIGN: Retrospective analysis of patient charts from January 1, 1972, to December 31, 1998.
SETTING: Tertiary pediatric referral center. PATIENTS: Twenty-nine consecutive children with nonorbital head and neck rhabdomyosarcoma.
INTERVENTIONS: Surgery, chemotherapy, and radiotherapy. MAIN OUTCOME MEASURES: Disease-free survival and long-term morbidity from treatment.
RESULTS: Twenty patients had parameningeal and 9 had nonparameningeal head and neck tumors. All were treated with chemotherapy. For 18 patients, diagnostic biopsies were performed and they received radiotherapy. Eleven patients underwent surgery as definitive therapy. Using the Intergroup Rhabdomyosarcoma Study (IRS) staging system, 5 of these 11 patients had complete resection of tumor (IRS group I) and avoided radiotherapy. The other 6 patients required radiation because of compromised, regional, or incomplete resection of tumor. One had undergone regional resection with nodal involvement, and 2 had compromised resections with microscopic residual disease (IRS group II). Three had incomplete resections with gross residual tumor (IRS group III). Only 1 patient who underwent surgery ultimately died from recurrence at 2.7 years after an incomplete resection. The other 10 patients were relapse free at a median follow-up of 3.7 years (range 0.8-21.0 years). Long-term surgical morbidity was seen in 36% (4/11) of the patients and included facial nerve paralysis, trismus, and cosmetic deformity.
CONCLUSIONS: Children with localized disease of the head and neck are able to undergo complete surgical resection, with low long-term surgical morbidity. By undergoing complete surgical resection, these children are able to avoid radiotherapy and its long-term complications, with no compromise in survival.

Entities:  

Mesh:

Year:  2000        PMID: 10772299     DOI: 10.1001/archotol.126.4.468

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  16 in total

Review 1.  Rhabdomyosarcoma of the Head and Neck: A Multimodal Approach.

Authors:  Dana L Casey; Suzanne L Wolden
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-18

Review 2.  Pediatric rhabdomyosarcoma of the head and neck.

Authors:  M Boyd Gillespie; David T Marshall; Terry A Day; Allen O Mitchell; David R White; Julio C Barredo
Journal:  Curr Treat Options Oncol       Date:  2006-01

3.  [Polypoid lesions of the auditory canal in children].

Authors:  C Breunig; K Paliege; P Benter; S Ukrow; R O Seidl
Journal:  HNO       Date:  2015-05       Impact factor: 1.284

4.  Therapeutic outcome and prognostic factors in sinonasal rhabdomyosarcoma: a single-institution case series.

Authors:  Wanpeng Li; Hanyu Lu; Dehui Wang
Journal:  J Cancer Res Clin Oncol       Date:  2019-08-23       Impact factor: 4.553

5.  Head and neck rhabdomyosarcoma in children: a 20-year retrospective study at a tertiary referral center.

Authors:  Sophia Marie Häußler; Carmen Stromberger; Heidi Olze; Georg Seifert; Steffen Knopke; Arne Böttcher
Journal:  J Cancer Res Clin Oncol       Date:  2017-11-16       Impact factor: 4.553

6.  A strategy to avoid facial mutilation in orbital embryonal rhabdomyosarcoma.

Authors:  Stefan Zwerger; Lutz Günther; Arnulf Pekrun; Heico-Rüdiger Krause; Jan Rustemeyer
Journal:  Oral Maxillofac Surg       Date:  2010-12

7.  Minimally Invasive Approach for Resection of Parameningeal Rhabdomyosarcoma.

Authors:  Aileen Wertz; Brittny N Tillman; Jennifer V Brinkmeier; Tiffany A Glazer; Andrew D Kroeker; Steven E Sullivan; Erin L McKean
Journal:  J Neurol Surg B Skull Base       Date:  2016-12-12

8.  Management of pediatric head and neck rhabdomyosarcoma: A case-series of 36 patients.

Authors:  Joanna Radzikowska; Wojciech Kukwa; Andrzej Kukwa; Anna M Czarnecka; Maciej Kawecki; Fei Lian; Cezary Szczylik; Antoni Krzeski
Journal:  Oncol Lett       Date:  2016-09-01       Impact factor: 2.967

9.  Rhabdomyosarcoma: a rare laryngeal neoplastic entity.

Authors:  B Pittore; G Fancello; P Cossu Rocca; G P Ledda; G Tore
Journal:  Acta Otorhinolaryngol Ital       Date:  2010-02       Impact factor: 2.124

10.  Pediatric sinonasal rhabdomyosarcoma: A case report.

Authors:  Asli Bostanci; Mehmet Asik; Murat Turhan
Journal:  Exp Ther Med       Date:  2015-10-30       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.